The relationship between vascular endothelial growth factor (VEGF) in the serum and drained dialysate with the quality of peritoneal dialysis and peritoneal membrane transport rates


  • Nataša Ž. Jovanović Clinic of Nephrology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade
  • Snežana S. Žunić Institute of Pathophysiology, Faculty of Medicine, University of Belgrade
  • Jasna B. Trbojević-Stanković Clinic of Urology, University Clinical Center “Dr Dragiša Mišović – Dedinje”, Faculty of Medicine, University of Belgrade
  • Željko D. Laušević Institute for Digestive diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade
  • Dejan M. Nešić Institute of Medical Physiology, Faculty of Medicine, University of Belgrade
  • Biljana B. Stojimirović Clinic of Nephrology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade


dialysis quality, peritoneal dialysis, peritoneal equilibration test, residual renal function, vascular endothelial growth factor


Paper description:

  • Chronic exposure to glucose-based peritoneal dialysis (PD) solutions causes peritoneal injury as a result of upregulation of vascular endothelial growth factor (VEGF) with proinflammatory and proangiogenetic activities.
  • Few studies have examined the in vivo effects of VEGF on the peritoneal membrane in humans.
  • Observed significant inverse correlations between drained dialysate VEGF concentrations, residual diuresis and residual renal function at chronic PD onset point to the importance of preserved residual renal function in achieving VEGF clearance.
  • The predictive value of drained dialysate VEGF in identifying patients with preserved transport characteristics of peritoneal membrane and efficacious long term PD maintenance is emphasized.

Abstract: Vascular endothelial growth factor (VEGF), a powerful angiogenetic agent crucial for microvascular hyperpermeability and neoangiogenesis in the peritoneum, is associated with increased solute transport rates in chronic peritoneal dialysis (PD) patients. We investigated the correlation between serum and drained dialysate (dd) concentrations of VEGF and the transport characteristics of peritoneal membrane and dialysis quality in 20 patients with end-stage renal failure at the beginning and after six months of PD. The serum VEGF (sVEGF) concentration rose significantly (149.33±116.71 pg/mL vs 239.36±102.23 pg/mL; p=0.012) and ddVEGF concentration increased slightly (38.44±50.47 pg/mL vs 43.55±51.10 pg/mL) during the first 6 months of PD. At the beginning of chronic PD, ddVEGF concentrations correlated inversely with the peritoneal equilibrium test (PET) glucose (R=-0.565; p=0.009) and creatinine (R=-0.506; p=0.023) and residual renal function (RRF) (R=-0.691; p=0.001); sVEGF concentrations inversely correlated with PET creatinine (R=-0.457; p=0.043) and residual diuresis (RD) (R=-0.691; p=0.001). After 6 months of treatment, ddVEGF concentrations correlated directly with PETcreatinine (R=0.450; p=0.047), and inversely with RRF (R=-0.552; p=0.012) and residual renal weekly Kt/V (R=-0.488; p=0.029). The sVEGF concentration inversely correlated with RD (R=-0.589; p=0.006). High ddVEGF at the beginning of PD is predictive of adverse alterations of the peritoneal membrane, i.e. increased transport rate of glucose and creatinine. ddVEGF values may help to identify patients who will preserve adequate transport characteristics of the peritoneal membrane and maintain successful long-term PD.

Received: November 20, 2018; Revised: December 19, 2018; Accepted: December 22 2018; Published online: December 27, 2018

How to cite this article: Jovanović NŽ, Žunić SS, Trbojević-Stanković JB, Laušević ŽD, Nešić DM, Stojimirović BB. The relationship between vascular endothelial growth factor (VRGF) in the serum and drained dialysate with the quality of peritoneal dialysis and peritoneal membrane transport rates. Arch Biol Sci. 2018;71(1):187-94.


Download data is not yet available.


Krediet RT, Struijk DG. Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol. 2013;9:419-29.

Schilte MN, Celie JW, ter We PM, Beelen RHJ, van den Born J. Factors contributing to peritoneal tissue remodelling in peritoneal dialysis. Perit Dial Int. 2009;29:605-17.

Gao D, Zhao ZZ, Liang XH, Li Y, Cao Y, Liu ZS. Effects of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients. Nephrology. 2011;16:736-42.

Jovanović N, Žunić Božinovski S, Krstić S, Obrenović R, Trbojević-Stanković J, Stojimirović B. Vascular Endothelial Growth Factor in Peritoneal Dialysis Patients. Clin Lab. 2014;60:1695-701.

Stojimirović B, Jovanović N, Trbojević-Stanković J, Krstić S, Nešić D, Žunić-Božinovski S. Levels of vascular endothelial growth factor during first six months of peritoneal dialysis. Srp Arh Celok Lek. 2015:143(9-10):578-83.

Aguirre AR, Abensur H. Protective measures against ultrafiltration failure in peritoneal dialysis patients. Clinics. 2011;66(12):2151-7.

Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 2000;80(1):99-115.

Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(3):4-10.

Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial In. 2002;22:171-7.

Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M. Diabetic Retinopathy and VEGF. Open Ophthalmol J. 2013;7:4-10.

Heimbürger O. Peritoneal transport with icodextrin solution. Contrib Nephrol. 2006;150:97-103.

Zweers MM, Struijk DG, Smit W, Krediet RT. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J Lab Clin Med. 2001;137:125-32.

Van Esch S, Zweers MM, Jansen MA, de Waart DR, van Manen JG, Krediet RT. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int. 2004;24:554-61.

Pecoits-Filho R, Araújo MR, Lindholm B, Stenvinkel P, Abensur H, Romão JE, Marcondes M, de Oliveira AHF, Noronha IL. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant. 2002;17:1480-6.

Szeto CC, Chow KM, Poon P, Szeto CYK, Wong TYH, Li PKT. Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int. 2004;65:1947-55.

Gotch F. What is important in dialysis? Efficiency: blood flow, KoA and Kt/V? Contrib Nephrol. 2008;161:168-77.

Basile C, Vernaglione L, Bellizzi V, Lomonte C, Rubino A, D’Ambrosio N, Di Iorio B. Total body water in health and disease: Have anthropometric equations any meaning? Nephrol Dial Transplant. 2008;23(6):1997-2002.

Ruggieri G, Rocca AR. Analysis of past and present methods of measuring and estimating body surface area and the resulting evaluation of its doubtful suitability to universal application. Blood Purif. 2010;30(4):296-305.

Jovanović N, Trbojević-Stanković J, Nešić D, Obrenović R, Boričić N, Stojimirović B. Cancer antigen 125 concentration in patients on chronic peritoneal dialysis treatment – relationship with dialysis quality and membrane transport properties. Arch Biol Sci. 2018;70(1):13-20.

Szeto CC, Chow KM, Leung CB, Wong TY, Li PK. Assessment of protein nitrogen appearance in Chinese peritoneal dialysis patients-which method to use? Ren Fail. 2003;25(2):235-46.

Prowant BF, Moore HL, Twardowski ZJ, Khanna R. Understanding discrepancies in peritoneal equilibration test results. Perit Dial Int. 2010;30(3):366-70.

Stompór T, Zdzienicka A, Motyka M, Dembińska-Kiec A, Davies SJ, Sulowicz W. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function and peritoneal membrane transport. Perit Dial Int. 2002;22:670-6.

Cho JH, Hur IK, Kim CD, Park SH, Ryu HM, Yook JM, Choi JY, Choi HJ, Choi HJ, Park JW, Do JY, Kim YL. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol Dial Transplant. 2010;25(6):1964-73.

Aguilera A, Sánchez-Tomero JA, Bajo MA, Ruiz-Caravaca ML, Alvarez V, del Peso G, Herranz A, Cuesta MV, Castro MJ, Selgas R. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial. 2003;19:240-5.

Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int. 2003;63(Suppl. 84):S151-61.

Liu J, Wu X, Liu Y, Xu Y, Huang Y, Xing C, Wang X. High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin. Int J Mol Med. 2013;32(5):1150-8.




How to Cite

Jovanović N Ž., Žunić SS, Trbojević-Stanković JB, Laušević Željko D, Nešić DM, Stojimirović BB. The relationship between vascular endothelial growth factor (VEGF) in the serum and drained dialysate with the quality of peritoneal dialysis and peritoneal membrane transport rates. Arch Biol Sci [Internet]. 2019Apr.2 [cited 2022Aug.18];71(1):187-94. Available from:




Most read articles by the same author(s)